Pain Management in End-Stage Renal Disease (ESRD) Patients

Introduction to Pain Management in ESRD

The American Geriatrics Society recommends acetaminophen as first-line therapy at up to 4 grams per 24 hours in adults with ESRD 3
The American Society of Clinical Oncology (ASCO) explicitly states that tramadol should be avoided in patients with renal impairment unless there are no alternatives 1
The American College of Physicians recommends avoiding tramadol in severe renal impairment (GFR <30 mL/min/1.73 m²) and ESRD due to risk of metabolite accumulation and toxicity 2

Paracetamol is the preferred first-line analgesic for ESRD patients and can be used safely at standard therapeutic doses 3
The primary safety concern is hepatic toxicity, not renal toxicity—strictly adhere to the 4-gram daily maximum from all sources 3
Paracetamol is safer than NSAIDs, which carry significant risks of gastrointestinal bleeding and cardiovascular toxicity in ESRD 3

Tramadol should be avoided in ESRD (GFR <30 mL/min) due to accumulation of the parent drug and active metabolites, leading to increased risk of seizures, respiratory depression, and neurotoxicity 1, 2
Risk of seizures is significantly increased in patients with renal impairment 2
Tramadol increases serotonergic activity, raising risk of serotonin syndrome when combined with SSRIs, TCAs, or MAOIs 2, 4

The National Comprehensive Cancer Network (NCCN) guidelines recommend lower doses for patients with renal dysfunction to reduce seizure risk 4, 2
Methadone, fentanyl, and buprenorphine are preferred opioids in ESRD, in order of safety 1, 4
Oxycodone and hydromorphone can be used with caution and dose reduction 1
Morphine, codeine, and meperidine should be avoided entirely due to accumulation of toxic metabolites 1